BIONEER CORPORATION

Bioneer Participates in Dubai Derma 2025 to advertise CosmeRNA

Bioneer announced on April 17 that it participated in “Dubai Derma 2025,” held from April 14 to 16 in Dubai, United Arab Emirates. During the event, the company operated a booth for its hair loss cosmetic brand, CosmeRNA, and conducted various marketing activities.

“Dubai Derma 2025” is one of the world’s leading conferences and exhibitions in the dermatology and aesthetics industry. This year’s event was held on the largest scale to date, attracting over 24,000 dermatologists and industry professionals from 114 countries. Bioneer showcased its RNA-based hair loss cosmetic, CosmeRNA, highlighting its scientific uniqueness and clinical effectiveness to distribution partners and clinic experts in the Middle East region. Over the course of the exhibition, the company held consultations with 43 companies from 25 countries, confirming strong interest from clients across the Middle East, including major European markets.

The exhibition was jointly operated with Bioneer’s exclusive distributor in the UAE, ATLAS MEDICAL LLC. Dermatologists and industry professionals who visited the booth expressed great interest in CosmeRNA’s scientific originality and real-world clinical data. They were particularly impressed by its convenience of use—applied topically just once a week—and its follicle-targeted mechanism of action.

On the second day of the exhibition, a CosmeRNA dinner seminar hosted by ATLAS MEDICAL LLC. was held. Approximately 30 key opinion leaders (KOLs) and local medical professionals from countries such as the UAE, Jordan, and Kuwait attended to share their experiences and insights regarding CosmeRNA. Female doctors, who primarily treat female hair loss patients, showed especially strong interest in the product’s clinical use cases among women, actively engaging in a Q&A session. Attendees took note of CosmeRNA’s unique RNA-based formulation, which acts exclusively within the hair follicle, minimizes side effects, and offers a convenient once-a-week application. They also discussed future plans to expand the supply of the clinic-exclusive product, CosmeRNA™ ARI Intensive, as well as home-care product lines.

A Bioneer representative stated, “This year’s Dubai Derma 2025 featured more companies than ever before, including many similar products containing the same active ingredient. However, CosmeRNA stood out as a patented product with exclusive substance patents granted in major countries worldwide. The clinical results shared by early adopters drew significant attention from experts and customers alike.” The spokesperson added, “Based on the strong customer response and the business potential confirmed at the exhibition, we will actively expand our business in the Middle East and Europe.”